StockData
Cognition Therapeutics Inc logo

Cognition Therapeutics Inc (CGTX) stock

CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.63−0.01 (-1.39%)

Close on Nov 17, 2026Market cap $59.90MP/E –Yield –

Cognition Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Cognition Therapeutics's enterprise value was $30.37M on Nov 11, 2026, against $114.25M a year earlier. Over the last 5 years it ranged from -$9.74M to $147.12M, with a median of $10.04M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$30.37M-62.0%
2025Dec 31, 2025$79.83M+1108.4%
2024Dec 31, 2024$6.61M-71.6%
2023Dec 29, 2023$23.30M+525.4%
2022Dec 30, 2022$3.73M–
2021Dec 31, 2021-$4.42M–

More Cognition Therapeutics figures

See a number that looks wrong?